David M Lubaroff

Title: David M Lubaroff: Innovator in Cancer Vaccines

Introduction

David M Lubaroff is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of cancer research, particularly in the development of vaccines aimed at producing protective responses against cancer. His innovative work has the potential to impact the lives of many individuals affected by this disease.

Latest Patents

David M Lubaroff holds a patent for "Cancer vaccines and methods of producing and using same." This patent describes a method of vaccinating a subject to produce a cancer protective response. The first vaccine comprises an adenovirus vector that includes at least one nucleic acid molecule designed to elicit a cancer protective response. This is followed by one or more second vaccines that consist of an alphavirus replicon particle containing RNA derived from the nucleic acid molecule. Notably, this method has applications in treating prostate cancer. He has 1 patent to his name.

Career Highlights

Throughout his career, David has worked with esteemed organizations, including the University of Iowa Research Foundation and the United States Government as represented by the Department of Veterans Affairs. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

David M Lubaroff has collaborated with various professionals in his field, including Delbert Linn Harris. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

David M Lubaroff is a pioneering inventor whose work in cancer vaccines showcases his commitment to advancing medical science. His innovative approaches have the potential to change the landscape of cancer treatment and improve patient outcomes.